STEVIOL GLYCOSIDES (addendum) 215 Curry, L.L. & Roberts, A. (2008) Subchronic toxicity <strong>of</strong> rebaudioside A. Food Chem. Toxicol., 46(7)(Suppl. 1), S11–S20. Curry, L.L., Roberts, A. & Brown, N. (2008) Rebaudioside A: two generation reproductive toxicity study in rats. Food Chem. Toxicol., 46(7)(Suppl. 1), S21–S30. De-Yi, X., Hong, C. & Yuan-Yuan, L. (1990) The antihypertensive effects by stevioside in the conscious normal and hypertensive rats. Eur. J. Pharmacol., 183, 1822 (Abstract No. P.th.182). Dyrskog, S.E.U., Jeppesen, P.B., Colombo, M., Abudula, R. & Hermansen, K. (2005a) Preventative effects <strong>of</strong> a soy-based diet supplemented with stevioside on the development <strong>of</strong> the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism, 54, 1181–1188. Dyrskog, S.E.U., Jeppesen, P.B., Chen, J., Christensen, L.P. & Hermansen, K. (2005b) The diterpene glycoside, rebaudioside A, does not improve glycemic control or affect blood pressure after 8 weeks treatment in Goto-Kakizaki rat. Rev. Diabet. Stud., 2, 84–91. Ferreira, E.B., Neves, F.A.R., da Costa, M.A.D., do Prado, W.A., Ferri, L.A.F. & Bazotte, R.B. (2006) Comparative effects <strong>of</strong> Stevia rebaudiana leaves and stevioside on glycaemia and hepatic gluconeogenesis. Planta Med., 72, 691–696. Ferri, L.A.F., Alves-Do-Prado, W., Yamada, S.S., Gazola, S., Batista, M.R. & Bazotte, R.B. (2006) Investigation <strong>of</strong> the antihypertensive effect <strong>of</strong> oral crude stevioside in patients with mild hypertension. Phytother. Res., 20, 732–736. Geuns, J.M.C. (2007) Comments to the paper by Nunes et al. (2007), Analysis <strong>of</strong> genotoxic potential <strong>of</strong> stevioside by comet assay, Food and Chemical Toxicology 45 (2007), 662–666. Food Chem. Toxicol., 45, 2601–2602. Geuns, J.M.C., Buyse, J., Vankeirsbilck, A. & Temme, E.H.M. (2007) Metabolism <strong>of</strong> stevioside by healthy subjects. Exp. Biol. Med., 232, 164–173. Geuns, J.M.C., Buyse, J., Vankeirsbilck, A., Temme, E.H.M., Compernolle, F. & Toppet S. (2006) Identification <strong>of</strong> steviol glucuronide in human urine. J. Agric. Food Chem., 54, 2794–2798. Ghanta, S., Banerjee, A., Poddar, A. & Chattopadhyay, S. (2007) Oxidative DNA damage preventative activity and antioxidant potential <strong>of</strong> Stevia rebaudiana (Bertoni) Bertoni, a natural sweetener. J. Agric. Food Chem., 55, 10962–10967. Gorbenko, N., Poltorak, V., Gladkih, A., Ivanova, O., Khudyakova, E., Gorbenko, K. & Gorshunska, M. (2005) Natural sweetener stevioside improves lipid pr<strong>of</strong>ile and ameliorates oxidative stress in diabetic rabbits. Diabetologia, 48(Suppl. 1), A273 (Abstract No. 754). Hohn, S. & Zankl, H. (1990) Mutagenic effects <strong>of</strong> stevioside in vitro and in vivo. Mutagenesis, 5(6), 622 (Abstract No. 16). Hong, J., Chen, L. & Jeppesen, P.B. (2006) Stevioside counteracts the -cell hypersecretion caused by long term palmitate exposure. Am. J. Physiol. Endocrin. Metab., 290, E416–E422. Hsieh, M., Chan, P., Sue, Y., Liu, J., Liang, T., Huang, T., Tomlinson, B., Chow, M.S., Kao, P. & Chen, Y. (2003) Efficacy and tolerability <strong>of</strong> oral stevioside in patients with mild essential hypertension: a two-year, randomised, placebo-controlled study. Clin. Ther., 25, 2797–2808. Hutapea, A.M., Toskukao, C., Buddhasukh, D., Wilairat, P. & Glinsukon, T. (1997) Digestion <strong>of</strong> stevioside, a natural sweetener, by various digestive enzymes. J. Clin. Biochem. Nutr., 23, 177–186. Jeppesen, P.B., Gregersen, S. & Hermansen, K. (1996) Stevioside and steviol stimulate insulin secretion from isolated mouse islets. Diabetologia, 39, A125 (Abstract No. 472). Jeppesen, P.B., Barriocanal, L., Meyer, M.T., Palacios, M., Canete, F., Benitez, S., Logwin, S., Schupmann, Y., Benitez, G. & Jimenez, J.T. (2006) Efficacy and tolerability <strong>of</strong> oral stevioside in patients with type 2 diabetes: a long-term, randomized, doubleblinded, placebo-controlled study. Diabetologia, 49(Suppl. 1), 511–512 (Abstract No. 0843).
216 STEVIOL GLYCOSIDES (addendum) Kawamori, T., Tanaka, T., Hara, A., Yamahara, J. & Mori, H. (1995) Modifying effects <strong>of</strong> naturally occurring products on the development <strong>of</strong> colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res., 55, 1277–1282. Kimata, H. (2007) Anaphylaxis by stevioside in infants with atopic eczema. Allergy, 62, 565–566. Klongpanichpak, S., Toskulkao, C., Temcharoen, P., Apibal, S. & Glinsukon, T. (1997) Lack <strong>of</strong> mutagenicity <strong>of</strong> stevioside and steviol in Salmonella typhimurium TA98 and TA100. J. Med. Assoc. Thai., 80(1), 121–128. Kraemer, T. & Maurer, H.H. (1994) On the metabolism <strong>of</strong> the sweetener stevioside in humans. Eur. J. Pharm. Sci., 2, 103 (Abstract No. FC12). Lee, S.J., Lee, K.R., Park, J.R., Kim, K.S. & Tchai, B.S. (1979) [A study on the safety <strong>of</strong> stevioside as a new sweetening source.] Hanguk Sikpum Kwahakhoe Chi, 11, 224–231 (in Korean). Levy, N., Bracht, A. & Kelmer-Bracht, A.M. (1994) Effects <strong>of</strong> Stevia rebaudiana natural products on the mitochondrial L-glutamate dehydrogenase. Arq. Biol. Tecnol., 37(3), 673–680. Ma, J., Ma, Z., Wang, J., Milne, R.W., Xu, D., Davey, A.K. & Evans, A.M. (2007) Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes Obes. Metab., 9, 597–599. Maier, V., Mermann, K. & Kienle, U. (2003) Isolated perfused gut absorption <strong>of</strong> glucose is inhibited by steviol, a degradation product <strong>of</strong> the sweetener stevioside. Diabetes, 52(1), A554 (Abstract No. 2401-PO). Maki, K.C., Curry, L.L., McKenny, J.M., Farmer, M.V., Reeves, M.S., Dicklin, M.R., Gerich, J.E. & Zinman, B. (2007) Glycemic and blood pressure responses to acute doses <strong>of</strong> rebaudioside A, a steviol glycoside, in men and women with normal glucose tolerance or type 2 diabetes mellitus. Unpublished report from Provident Clinical Research, Bloomington, IN, USA. Submitted to WHO by Cargill Inc. Maki, K.C., Curry, L.L., Carakostas, M.C., Tarka, S.M., Reeves, M.S., Farmer, M.V., McKenny, J.M., Toth, P.D., Schwartz, S.L., Lubin, B.C., Dicklin, M.R., Boileau, A.C. & Bisognano, J.D. (2008a) The hemodynamic effects <strong>of</strong> rebaudioside A in healthy adults with normal and low-normal blood pressure. Food Chem. Toxicol., 46(7)(Suppl. 1), S40–S46. Maki, K.C., Curry, L.L., Reeves, M.S., Toth, P.D., McKenny, J.M., Farmer, M.V., Schwartz, S.L., Lubin, B.C., Boileau, A.C., Dicklin, M.R., Carakostas, M.C. & Tarka, S.M. (2008b) Chronic consumption <strong>of</strong> rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem. Toxicol., 46(7)(Suppl. 1), S47–S53. Malaisse, W.J., Vanonderbergen, A., Louchami, K., Jijakli, H. & Malaisse-Lagae, F. (1998) Effects <strong>of</strong> artificial sweeteners on insulin release and cationic fluxes in rat pancreatic islets. Cell Signal., 10(10), 727–733. Nakamura, M., Kodama, N., Sataoh, N., Nakamura, T. & Shingo (2003) Effect <strong>of</strong> stevioside on the expression <strong>of</strong> insulin receptor substrate-1 and -2. J. Pharmacol. Sci., 91, 115P (Abstract No. 1P014). Nikiforov, A.I. & Eapen, A.K. (2008) A 90-day oral (dietary) toxicity study <strong>of</strong> rebaudioside A in Sprague-Dawley rats. Int. J. Toxicol., 27, 65–80. Nunes, P. & Pereira, N.A. (1988) [The effect <strong>of</strong> Stevia rebaudiana on the fertility <strong>of</strong> experimental animals.] Rev. Bras. Farm., 69, 46–50 (in Portuguese). Nunes, A.P.M., Ferreira-Machado, S.C., Nunes, R.M., Dantas, F.J.S., Mattos, J.C.P. & Caldeira-de-Araujo, A. (2007) Analysis <strong>of</strong> genotoxic potential <strong>of</strong> stevioside by comet assay. Food Chem. Toxicol., 45, 662–666 [see also Responses in Food Chem. Toxicol., 45, 2599– 2600 and 45, 2603–2604]. Oh, H.Y., Han, E.S., Sohn, S.J., Kim, J.W., Park, C.H., Eom, M.O. & Ha, K.W. (1999b) Evaluation <strong>of</strong> the genotoxicity <strong>of</strong> stevioside and steviol using in vitro mouse lymphoma
- Page 2 and 3:
WHO FOOD ADDITIVES SERIES: 60 Safet
- Page 4 and 5:
CONTENTS Preface ..................
- Page 6:
PREFACE The monographs contained in
- Page 10 and 11:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 12 and 13:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 14 and 15:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 16 and 17:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 18 and 19:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 20:
ASPARAGINASE FROM ASPERGILLUS NIGER
- Page 23 and 24:
16 CALCIUM LIGNOSULFONATE (40-65) 1
- Page 25 and 26:
18 CALCIUM LIGNOSULFONATE (40-65) ~
- Page 27 and 28:
20 CALCIUM LIGNOSULFONATE (40-65) A
- Page 29 and 30:
22 CALCIUM LIGNOSULFONATE (40-65) c
- Page 31 and 32:
24 CALCIUM LIGNOSULFONATE (40-65) T
- Page 33 and 34:
26 CALCIUM LIGNOSULFONATE (40-65) 2
- Page 35 and 36:
28 CALCIUM LIGNOSULFONATE (40-65) i
- Page 37 and 38:
30 CALCIUM LIGNOSULFONATE (40-65) T
- Page 39 and 40:
32 CALCIUM LIGNOSULFONATE (40-65) T
- Page 41 and 42:
34 CALCIUM LIGNOSULFONATE (40-65) T
- Page 43 and 44:
36 CALCIUM LIGNOSULFONATE (40-65) 6
- Page 46 and 47:
ETHYL LAUROYL ARGINATE First draft
- Page 48 and 49:
ETHYL LAUROYL ARGINATE 41 and Devel
- Page 50 and 51:
ETHYL LAUROYL ARGINATE 43 lauroyl a
- Page 52 and 53:
ETHYL LAUROYL ARGINATE 45 arginine.
- Page 54 and 55:
ETHYL LAUROYL ARGINATE 47 resulting
- Page 56 and 57:
ETHYL LAUROYL ARGINATE 49 Table 4.
- Page 58 and 59:
ETHYL LAUROYL ARGINATE 51 weight ch
- Page 60 and 61:
ETHYL LAUROYL ARGINATE 53 stomach l
- Page 62 and 63:
ETHYL LAUROYL ARGINATE 55 fibrosis
- Page 64 and 65:
ETHYL LAUROYL ARGINATE 57 Table 5 (
- Page 66 and 67:
ETHYL LAUROYL ARGINATE 59 first 4 d
- Page 68 and 69:
ETHYL LAUROYL ARGINATE 61 The gener
- Page 70 and 71:
ETHYL LAUROYL ARGINATE 63 treatment
- Page 72 and 73:
ETHYL LAUROYL ARGINATE 65 gestation
- Page 74 and 75:
ETHYL LAUROYL ARGINATE 67 Body weig
- Page 76 and 77:
ETHYL LAUROYL ARGINATE 69 Table 6.
- Page 78 and 79:
ETHYL LAUROYL ARGINATE 71 Table 7 (
- Page 80 and 81:
ETHYL LAUROYL ARGINATE 73 Table 7 (
- Page 82 and 83:
ETHYL LAUROYL ARGINATE 75 Table 7 (
- Page 84 and 85:
ETHYL LAUROYL ARGINATE 77 About 99%
- Page 86 and 87:
ETHYL LAUROYL ARGINATE 79 concentra
- Page 88 and 89:
ETHYL LAUROYL ARGINATE 81 theoretic
- Page 90 and 91:
ETHYL LAUROYL ARGINATE 83 Huntingdo
- Page 92 and 93:
PAPRIKA EXTRACT First draft prepare
- Page 94 and 95:
PAPRIKA EXTRACT 87 of capsanthin ra
- Page 96 and 97:
PAPRIKA EXTRACT 89 biochemical para
- Page 98 and 99:
PAPRIKA EXTRACT 91 Table 1. Sales o
- Page 100 and 101:
PAPRIKA EXTRACT 93 Table 2. Estimat
- Page 102 and 103:
PAPRIKA EXTRACT 95 The European Sci
- Page 104 and 105:
PAPRIKA EXTRACT 97 The potential di
- Page 106 and 107:
PAPRIKA EXTRACT 99 Hornero-Mendez,
- Page 108 and 109:
PAPRIKA EXTRACT 101 Appendix 1. Res
- Page 110 and 111:
PAPRIKA EXTRACT 103 Appendix 1. (co
- Page 112:
PAPRIKA EXTRACT 105 Appendix 1. (co
- Page 115 and 116:
108 PHOSPHOLIPASE C EXPRESSED IN PI
- Page 117 and 118:
110 PHOSPHOLIPASE C EXPRESSED IN PI
- Page 119 and 120:
112 PHOSPHOLIPASE C EXPRESSED IN PI
- Page 121 and 122:
114 PHOSPHOLIPASE C EXPRESSED IN PI
- Page 124 and 125:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 126 and 127:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 128 and 129:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 130 and 131:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 132 and 133:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 134 and 135:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 136 and 137:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 138 and 139:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 140 and 141:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 142 and 143:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 144 and 145:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 146 and 147:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 148 and 149:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 150 and 151:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 152 and 153:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 154 and 155:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 156 and 157:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 158 and 159:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 160 and 161:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 162 and 163:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 164 and 165:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 166 and 167:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 168 and 169:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 170:
PHYTOSTEROLS, PHYTOSTANOLS AND THEI
- Page 173 and 174: 166 POLYDIMETHYLSILOXANE (addendum)
- Page 175 and 176: 168 POLYDIMETHYLSILOXANE (addendum)
- Page 177 and 178: 170 POLYDIMETHYLSILOXANE (addendum)
- Page 179 and 180: 172 POLYDIMETHYLSILOXANE (addendum)
- Page 181 and 182: 174 POLYDIMETHYLSILOXANE (addendum)
- Page 183 and 184: 176 POLYDIMETHYLSILOXANE (addendum)
- Page 185 and 186: 178 POLYDIMETHYLSILOXANE (addendum)
- Page 187 and 188: 180 POLYDIMETHYLSILOXANE (addendum)
- Page 190 and 191: STEVIOL GLYCOSIDES (addendum) First
- Page 192 and 193: STEVIOL GLYCOSIDES (addendum) 185 r
- Page 194 and 195: STEVIOL GLYCOSIDES (addendum) 187 c
- Page 196 and 197: STEVIOL GLYCOSIDES (addendum) 189 a
- Page 198 and 199: STEVIOL GLYCOSIDES (addendum) 191 N
- Page 200 and 201: STEVIOL GLYCOSIDES (addendum) 193 2
- Page 202 and 203: STEVIOL GLYCOSIDES (addendum) 195 T
- Page 204 and 205: STEVIOL GLYCOSIDES (addendum) 197 a
- Page 206 and 207: STEVIOL GLYCOSIDES (addendum) 199 r
- Page 208 and 209: STEVIOL GLYCOSIDES (addendum) 201 l
- Page 210 and 211: STEVIOL GLYCOSIDES (addendum) 203 g
- Page 212 and 213: STEVIOL GLYCOSIDES (addendum) 205 T
- Page 214 and 215: STEVIOL GLYCOSIDES (addendum) 207 T
- Page 216 and 217: STEVIOL GLYCOSIDES (addendum) 209 t
- Page 218 and 219: STEVIOL GLYCOSIDES (addendum) 211 t
- Page 220 and 221: STEVIOL GLYCOSIDES (addendum) 213 s
- Page 224 and 225: STEVIOL GLYCOSIDES (addendum) 217 L
- Page 226: STEVIOL GLYCOSIDES (addendum) 219 W
- Page 229 and 230: 222 SULFITES: ASSESSMENT OF DIETARY
- Page 231 and 232: 224 SULFITES: ASSESSMENT OF DIETARY
- Page 233 and 234: 226 SULFITES: ASSESSMENT OF DIETARY
- Page 235 and 236: 228 SULFITES: ASSESSMENT OF DIETARY
- Page 237 and 238: 230 SULFITES: ASSESSMENT OF DIETARY
- Page 239 and 240: 232 SULFITES: ASSESSMENT OF DIETARY
- Page 241 and 242: 234 SULFITES: ASSESSMENT OF DIETARY
- Page 243 and 244: 236 SULFITES: ASSESSMENT OF DIETARY
- Page 245 and 246: 238 SULFITES: ASSESSMENT OF DIETARY
- Page 247 and 248: 240 SULFITES: ASSESSMENT OF DIETARY
- Page 249 and 250: 242 SULFITES: ASSESSMENT OF DIETARY
- Page 251 and 252: 244 SULFITES: ASSESSMENT OF DIETARY
- Page 253 and 254: 246 SULFITES: ASSESSMENT OF DIETARY
- Page 255 and 256: 248 SULFITES: ASSESSMENT OF DIETARY
- Page 257 and 258: 250 SULFITES: ASSESSMENT OF DIETARY
- Page 259 and 260: 252 SULFITES: ASSESSMENT OF DIETARY
- Page 261 and 262: 254 SULFITES: ASSESSMENT OF DIETARY
- Page 263 and 264: 256 SULFITES: ASSESSMENT OF DIETARY
- Page 265 and 266: 258 SULFITES: ASSESSMENT OF DIETARY
- Page 268: SAFETY EVALUATIONS OF GROUPS OF REL
- Page 271 and 272: 264 INTRODUCTION Figure 1. Procedur
- Page 274 and 275:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 276 and 277:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 278 and 279:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 280 and 281:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 282 and 283:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 284 and 285:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 286 and 287:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 288 and 289:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 290 and 291:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 292 and 293:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 294 and 295:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 296:
DIETARY EXPOSURE ASSESSMENT OF FLAV
- Page 299 and 300:
292 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 301 and 302:
294 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 303 and 304:
296 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 305 and 306:
298 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 307 and 308:
300 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 309 and 310:
302 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 311 and 312:
304 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 313 and 314:
306 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 315 and 316:
308 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 317 and 318:
310 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 319 and 320:
312 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 321 and 322:
314 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 323 and 324:
316 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 325 and 326:
318 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 327 and 328:
320 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 329 and 330:
322 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 331 and 332:
324 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 333 and 334:
326 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 335 and 336:
328 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 337 and 338:
330 ALIPHATIC BRANCHED-CHAIN SATURA
- Page 339 and 340:
332 ALIPHATIC LINEAR ,-UNSATURATED
- Page 341 and 342:
334 ALIPHATIC LINEAR ,-UNSATURATED
- Page 343 and 344:
336 ALIPHATIC LINEAR ,-UNSATURATED
- Page 345 and 346:
338 ALIPHATIC LINEAR ,-UNSATURATED
- Page 347 and 348:
340 ALIPHATIC LINEAR ,-UNSATURATED
- Page 349 and 350:
342 ALIPHATIC LINEAR ,-UNSATURATED
- Page 351 and 352:
344 ALIPHATIC LINEAR ,-UNSATURATED
- Page 353 and 354:
346 ALIPHATIC LINEAR ,-UNSATURATED
- Page 355 and 356:
348 ALIPHATIC LINEAR ,-UNSATURATED
- Page 358 and 359:
ALKOXY-SUBSTITUTED ALLYLBENZENES PR
- Page 360 and 361:
ALKOXY-SUBSTITUTED ALLYLBENZENES 35
- Page 362 and 363:
ALKOXY-SUBSTITUTED ALLYLBENZENES 35
- Page 364 and 365:
ALKOXY-SUBSTITUTED ALLYLBENZENES 35
- Page 366 and 367:
ALKOXY-SUBSTITUTED ALLYLBENZENES 35
- Page 368 and 369:
ALKOXY-SUBSTITUTED ALLYLBENZENES 36
- Page 370 and 371:
ALKOXY-SUBSTITUTED ALLYLBENZENES 36
- Page 372 and 373:
ALKOXY-SUBSTITUTED ALLYLBENZENES 36
- Page 374 and 375:
ALKOXY-SUBSTITUTED ALLYLBENZENES 36
- Page 376 and 377:
ALKOXY-SUBSTITUTED ALLYLBENZENES 36
- Page 378 and 379:
ALKOXY-SUBSTITUTED ALLYLBENZENES 37
- Page 380 and 381:
ALKOXY-SUBSTITUTED ALLYLBENZENES 37
- Page 382 and 383:
ALKOXY-SUBSTITUTED ALLYLBENZENES 37
- Page 384 and 385:
ALKOXY-SUBSTITUTED ALLYLBENZENES 37
- Page 386 and 387:
ALKOXY-SUBSTITUTED ALLYLBENZENES 37
- Page 388 and 389:
ALKOXY-SUBSTITUTED ALLYLBENZENES 38
- Page 390 and 391:
ALKOXY-SUBSTITUTED ALLYLBENZENES 38
- Page 392 and 393:
ALKOXY-SUBSTITUTED ALLYLBENZENES 38
- Page 394 and 395:
ALKOXY-SUBSTITUTED ALLYLBENZENES 38
- Page 396 and 397:
ALKOXY-SUBSTITUTED ALLYLBENZENES 38
- Page 398 and 399:
ALKOXY-SUBSTITUTED ALLYLBENZENES 39
- Page 400 and 401:
ALKOXY-SUBSTITUTED ALLYLBENZENES 39
- Page 402 and 403:
ALKOXY-SUBSTITUTED ALLYLBENZENES 39
- Page 404 and 405:
ALKOXY-SUBSTITUTED ALLYLBENZENES 39
- Page 406 and 407:
ALKOXY-SUBSTITUTED ALLYLBENZENES 39
- Page 408 and 409:
ALKOXY-SUBSTITUTED ALLYLBENZENES 40
- Page 410 and 411:
ALKOXY-SUBSTITUTED ALLYLBENZENES 40
- Page 412 and 413:
ALKOXY-SUBSTITUTED ALLYLBENZENES 40
- Page 414 and 415:
ALKOXY-SUBSTITUTED ALLYLBENZENES 40
- Page 416 and 417:
ALKOXY-SUBSTITUTED ALLYLBENZENES 40
- Page 418 and 419:
ALKOXY-SUBSTITUTED ALLYLBENZENES 41
- Page 420 and 421:
ALKOXY-SUBSTITUTED ALLYLBENZENES 41
- Page 422 and 423:
ALKOXY-SUBSTITUTED ALLYLBENZENES 41
- Page 424 and 425:
ALKOXY-SUBSTITUTED ALLYLBENZENES 41
- Page 426 and 427:
ALKOXY-SUBSTITUTED ALLYLBENZENES 41
- Page 428 and 429:
ALKOXY-SUBSTITUTED ALLYLBENZENES 42
- Page 430 and 431:
ALKOXY-SUBSTITUTED ALLYLBENZENES 42
- Page 432 and 433:
ALKOXY-SUBSTITUTED ALLYLBENZENES 42
- Page 434 and 435:
ALKOXY-SUBSTITUTED ALLYLBENZENES 42
- Page 436 and 437:
ALKOXY-SUBSTITUTED ALLYLBENZENES 42
- Page 438 and 439:
ALKOXY-SUBSTITUTED ALLYLBENZENES 43
- Page 440 and 441:
ALKOXY-SUBSTITUTED ALLYLBENZENES 43
- Page 442 and 443:
ALKOXY-SUBSTITUTED ALLYLBENZENES 43
- Page 444 and 445:
ALKOXY-SUBSTITUTED ALLYLBENZENES 43
- Page 446 and 447:
ALKOXY-SUBSTITUTED ALLYLBENZENES 43
- Page 448 and 449:
ALKOXY-SUBSTITUTED ALLYLBENZENES 44
- Page 450 and 451:
ALKOXY-SUBSTITUTED ALLYLBENZENES 44
- Page 452 and 453:
ALKOXY-SUBSTITUTED ALLYLBENZENES 44
- Page 454 and 455:
ALKOXY-SUBSTITUTED ALLYLBENZENES 44
- Page 456 and 457:
ALKOXY-SUBSTITUTED ALLYLBENZENES 44
- Page 458 and 459:
ALKOXY-SUBSTITUTED ALLYLBENZENES 45
- Page 460 and 461:
ALKOXY-SUBSTITUTED ALLYLBENZENES 45
- Page 462 and 463:
ALKOXY-SUBSTITUTED ALLYLBENZENES 45
- Page 464 and 465:
ALKOXY-SUBSTITUTED ALLYLBENZENES 45
- Page 466 and 467:
ALKOXY-SUBSTITUTED ALLYLBENZENES 45
- Page 468 and 469:
ALKOXY-SUBSTITUTED ALLYLBENZENES 46
- Page 470 and 471:
ALKOXY-SUBSTITUTED ALLYLBENZENES 46
- Page 472 and 473:
ALKOXY-SUBSTITUTED ALLYLBENZENES 46
- Page 474 and 475:
ALKOXY-SUBSTITUTED ALLYLBENZENES 46
- Page 476 and 477:
ALKOXY-SUBSTITUTED ALLYLBENZENES 46
- Page 478 and 479:
ALKOXY-SUBSTITUTED ALLYLBENZENES 47
- Page 480 and 481:
ALKOXY-SUBSTITUTED ALLYLBENZENES 47
- Page 482 and 483:
ALKOXY-SUBSTITUTED ALLYLBENZENES 47
- Page 484 and 485:
ALKOXY-SUBSTITUTED ALLYLBENZENES 47
- Page 486 and 487:
ALKOXY-SUBSTITUTED ALLYLBENZENES 47
- Page 488 and 489:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 490 and 491:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 492 and 493:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 494 and 495:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 496 and 497:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 498 and 499:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 500 and 501:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 502 and 503:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 504 and 505:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 506 and 507:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 508 and 509:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 510 and 511:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 512 and 513:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 514 and 515:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 516 and 517:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 518 and 519:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 520 and 521:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 522 and 523:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 524 and 525:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 526 and 527:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 528 and 529:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 530 and 531:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 532 and 533:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 534 and 535:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 536 and 537:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 538 and 539:
FURAN-SUBSTITUTED ALIPHATIC HYDROCA
- Page 540 and 541:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 542 and 543:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 544 and 545:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 546 and 547:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 548 and 549:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 550 and 551:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 552 and 553:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 554 and 555:
HYDROXY- AND ALKOXY-SUBSTITUTED BEN
- Page 556 and 557:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 558 and 559:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 560 and 561:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 562 and 563:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 564 and 565:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 566 and 567:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 568 and 569:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 570 and 571:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 572 and 573:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 574 and 575:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 576 and 577:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 578 and 579:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 580 and 581:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 582 and 583:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 584:
MISCELLANEOUS NITROGEN-CONTAINING S
- Page 587 and 588:
580 SUBSTANCES STRUCTURALLY RELATED
- Page 589 and 590:
582 SUBSTANCES STRUCTURALLY RELATED
- Page 591 and 592:
584 SUBSTANCES STRUCTURALLY RELATED
- Page 593 and 594:
586 SUBSTANCES STRUCTURALLY RELATED
- Page 595 and 596:
588 SUBSTANCES STRUCTURALLY RELATED
- Page 597 and 598:
590 SUBSTANCES STRUCTURALLY RELATED
- Page 599 and 600:
592 SUBSTANCES STRUCTURALLY RELATED
- Page 602:
ANNEXES
- Page 605 and 606:
598 ANNEX 1 10. Specifications for
- Page 607 and 608:
600 ANNEX 1 No. 54, 1974; WHO Techn
- Page 609 and 610:
602 ANNEX 1 70. Evaluation of certa
- Page 611 and 612:
604 ANNEX 1 108. Toxicological eval
- Page 613 and 614:
606 ANNEX 1 148. Residues of some v
- Page 615 and 616:
608 ANNEX 1 188. Safety evaluation
- Page 617 and 618:
610 ANNEX 2 ECG electrocardiogram E
- Page 619 and 620:
612 ANNEX 2 SI stimulation index SU
- Page 621 and 622:
614 ANNEX 3 Ms J. Baines, Food Stan
- Page 624 and 625:
ANNEX 4 ACCEPTABLE DAILY INTAKES, O
- Page 626 and 627:
ANNEX 4 619 Food additive Specifica
- Page 628 and 629:
ANNEX 4 621 3. FLAVOURING AGENTS 3.
- Page 630 and 631:
ANNEX 4 623 Flavouring agent No. Sp
- Page 632 and 633:
ANNEX 4 625 Flavouring agent JECFA
- Page 634 and 635:
ANNEX 4 627 Actual production volum
- Page 636 and 637:
ANNEX 4 629 Flavouring agent No. Sp
- Page 638 and 639:
ANNEX 5 SUMMARY OF THE SAFETY EVALU
- Page 640 and 641:
ANNEX 5 633 Secondary components Co